
Keywords: ESRD, end-stage renal disease; PRA, panel-reactive antibodies; rHuEPO, recombinant human erythropoietin; HD, hemodialysis; PD, peritoneal dialysis; CKD, chronic kidney diseaseDialysis; End-stage renal disease; Human leukocyte antigen; Kidney transplantati